A tentative $26.9 million settlement has been reached in a two-year-old Delaware Chancery Court derivative suit accusing the former controlling investors and certain directors of global cannabis company Tilray Inc. of lining up a merger that unfairly favored the company's private equity founders, according to a letter Monday.